nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—PDE10A—decidua—uterine cancer	0.0443	0.143	CbGeAlD
Papaverine—PDE10A—female gonad—uterine cancer	0.0317	0.102	CbGeAlD
Papaverine—Blood pressure increased—Progesterone—uterine cancer	0.0285	0.0522	CcSEcCtD
Papaverine—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.0259	0.0473	CcSEcCtD
Papaverine—PDE3A—smooth muscle tissue—uterine cancer	0.0257	0.0829	CbGeAlD
Papaverine—PDE10A—lymph node—uterine cancer	0.0204	0.0657	CbGeAlD
Papaverine—PDE3A—female reproductive system—uterine cancer	0.0198	0.0639	CbGeAlD
Papaverine—PDE4B—uterine cervix—uterine cancer	0.0191	0.0615	CbGeAlD
Papaverine—PDE3B—lymph node—uterine cancer	0.019	0.0612	CbGeAlD
Papaverine—PDE4B—decidua—uterine cancer	0.0182	0.0586	CbGeAlD
Papaverine—PDE3A—female gonad—uterine cancer	0.0181	0.0581	CbGeAlD
Papaverine—PDE4B—endometrium—uterine cancer	0.0173	0.0556	CbGeAlD
Papaverine—Abdominal discomfort—Progesterone—uterine cancer	0.0172	0.0314	CcSEcCtD
Papaverine—PDE4B—mammalian vulva—uterine cancer	0.0167	0.0538	CbGeAlD
Papaverine—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0156	0.0285	CcSEcCtD
Papaverine—Hepatitis—Progesterone—uterine cancer	0.0143	0.0262	CcSEcCtD
Papaverine—PDE4B—female reproductive system—uterine cancer	0.0143	0.0461	CbGeAlD
Papaverine—PDE4B—female gonad—uterine cancer	0.013	0.0419	CbGeAlD
Papaverine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.013	0.0238	CcSEcCtD
Papaverine—PDE4B—vagina—uterine cancer	0.0129	0.0417	CbGeAlD
Papaverine—PDE3A—lymph node—uterine cancer	0.0116	0.0374	CbGeAlD
Papaverine—Ill-defined disorder—Progesterone—uterine cancer	0.0116	0.0212	CcSEcCtD
Papaverine—Malaise—Progesterone—uterine cancer	0.0113	0.0206	CcSEcCtD
Papaverine—Vertigo—Progesterone—uterine cancer	0.0112	0.0205	CcSEcCtD
Papaverine—Discomfort—Progesterone—uterine cancer	0.0105	0.0192	CcSEcCtD
Papaverine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.0105	0.0192	CcSEcCtD
Papaverine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0187	CcSEcCtD
Papaverine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0186	CcSEcCtD
Papaverine—Hepatitis—Dactinomycin—uterine cancer	0.0101	0.0185	CcSEcCtD
Papaverine—Anorexia—Progesterone—uterine cancer	0.00971	0.0178	CcSEcCtD
Papaverine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00951	0.0174	CcSEcCtD
Papaverine—Flushing—Dactinomycin—uterine cancer	0.0094	0.0172	CcSEcCtD
Papaverine—Decreased appetite—Progesterone—uterine cancer	0.00885	0.0162	CcSEcCtD
Papaverine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.0088	0.0161	CcSEcCtD
Papaverine—Constipation—Progesterone—uterine cancer	0.00871	0.0159	CcSEcCtD
Papaverine—Feeling abnormal—Progesterone—uterine cancer	0.00839	0.0154	CcSEcCtD
Papaverine—PDE4B—lymph node—uterine cancer	0.00837	0.0269	CbGeAlD
Papaverine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00818	0.015	CcSEcCtD
Papaverine—PDE3B—PKB-mediated events—STK11—uterine cancer	0.0081	0.0565	CbGpPWpGaD
Papaverine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00802	0.0147	CcSEcCtD
Papaverine—Malaise—Dactinomycin—uterine cancer	0.00795	0.0146	CcSEcCtD
Papaverine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00789	0.0144	CcSEcCtD
Papaverine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.0076	0.0139	CcSEcCtD
Papaverine—Discomfort—Dactinomycin—uterine cancer	0.00742	0.0136	CcSEcCtD
Papaverine—Diarrhoea—Progesterone—uterine cancer	0.00697	0.0128	CcSEcCtD
Papaverine—Anorexia—Dactinomycin—uterine cancer	0.00686	0.0126	CcSEcCtD
Papaverine—Flushing—Etoposide—uterine cancer	0.00681	0.0125	CcSEcCtD
Papaverine—Rash—Progesterone—uterine cancer	0.00642	0.0118	CcSEcCtD
Papaverine—Dermatitis—Progesterone—uterine cancer	0.00641	0.0117	CcSEcCtD
Papaverine—Headache—Progesterone—uterine cancer	0.00638	0.0117	CcSEcCtD
Papaverine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00631	0.0116	CcSEcCtD
Papaverine—Decreased appetite—Dactinomycin—uterine cancer	0.00626	0.0115	CcSEcCtD
Papaverine—Nausea—Progesterone—uterine cancer	0.00605	0.0111	CcSEcCtD
Papaverine—Feeling abnormal—Dactinomycin—uterine cancer	0.00593	0.0109	CcSEcCtD
Papaverine—Ill-defined disorder—Etoposide—uterine cancer	0.00592	0.0108	CcSEcCtD
Papaverine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00582	0.0106	CcSEcCtD
Papaverine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00581	0.0106	CcSEcCtD
Papaverine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00578	0.0106	CcSEcCtD
Papaverine—Malaise—Etoposide—uterine cancer	0.00576	0.0105	CcSEcCtD
Papaverine—Vertigo—Etoposide—uterine cancer	0.00573	0.0105	CcSEcCtD
Papaverine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00548	0.01	CcSEcCtD
Papaverine—Discomfort—Etoposide—uterine cancer	0.00537	0.00983	CcSEcCtD
Papaverine—Anorexia—Etoposide—uterine cancer	0.00497	0.00909	CcSEcCtD
Papaverine—Diarrhoea—Dactinomycin—uterine cancer	0.00492	0.00901	CcSEcCtD
Papaverine—Rash—Dactinomycin—uterine cancer	0.00454	0.00831	CcSEcCtD
Papaverine—Decreased appetite—Etoposide—uterine cancer	0.00453	0.00829	CcSEcCtD
Papaverine—Constipation—Etoposide—uterine cancer	0.00445	0.00815	CcSEcCtD
Papaverine—Feeling abnormal—Etoposide—uterine cancer	0.00429	0.00786	CcSEcCtD
Papaverine—Nausea—Dactinomycin—uterine cancer	0.00428	0.00783	CcSEcCtD
Papaverine—Hepatitis—Epirubicin—uterine cancer	0.00411	0.00752	CcSEcCtD
Papaverine—PDE4B—Myometrial Relaxation and Contraction Pathways—CALD1—uterine cancer	0.00405	0.0283	CbGpPWpGaD
Papaverine—PDE3B—PI3K Cascade—STK11—uterine cancer	0.00398	0.0278	CbGpPWpGaD
Papaverine—Flushing—Epirubicin—uterine cancer	0.00381	0.00698	CcSEcCtD
Papaverine—Hepatitis—Doxorubicin—uterine cancer	0.0038	0.00696	CcSEcCtD
Papaverine—Diarrhoea—Etoposide—uterine cancer	0.00356	0.00652	CcSEcCtD
Papaverine—Flushing—Doxorubicin—uterine cancer	0.00353	0.00646	CcSEcCtD
Papaverine—PDE3B—Leptin signaling pathway—SOCS3—uterine cancer	0.00345	0.0241	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—STK11—uterine cancer	0.00333	0.0233	CbGpPWpGaD
Papaverine—Ill-defined disorder—Epirubicin—uterine cancer	0.00332	0.00608	CcSEcCtD
Papaverine—Rash—Etoposide—uterine cancer	0.00328	0.00601	CcSEcCtD
Papaverine—Dermatitis—Etoposide—uterine cancer	0.00328	0.00601	CcSEcCtD
Papaverine—Headache—Etoposide—uterine cancer	0.00326	0.00597	CcSEcCtD
Papaverine—PDE3B—IRS-related events—STK11—uterine cancer	0.00324	0.0226	CbGpPWpGaD
Papaverine—Malaise—Epirubicin—uterine cancer	0.00323	0.00591	CcSEcCtD
Papaverine—Vertigo—Epirubicin—uterine cancer	0.00321	0.00588	CcSEcCtD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—STK11—uterine cancer	0.00321	0.0224	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—STK11—uterine cancer	0.00313	0.0218	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—STK11—uterine cancer	0.00313	0.0218	CbGpPWpGaD
Papaverine—PDE3B—PI3K Cascade—FGFR2—uterine cancer	0.00311	0.0217	CbGpPWpGaD
Papaverine—Nausea—Etoposide—uterine cancer	0.00309	0.00566	CcSEcCtD
Papaverine—Ill-defined disorder—Doxorubicin—uterine cancer	0.00307	0.00562	CcSEcCtD
Papaverine—Discomfort—Epirubicin—uterine cancer	0.00301	0.00551	CcSEcCtD
Papaverine—Malaise—Doxorubicin—uterine cancer	0.00299	0.00546	CcSEcCtD
Papaverine—Vertigo—Doxorubicin—uterine cancer	0.00297	0.00544	CcSEcCtD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—IGF1R—uterine cancer	0.0028	0.0195	CbGpPWpGaD
Papaverine—Discomfort—Doxorubicin—uterine cancer	0.00278	0.0051	CcSEcCtD
Papaverine—Anorexia—Epirubicin—uterine cancer	0.00278	0.00509	CcSEcCtD
Papaverine—PDE3B—IGF1R signaling cascade—IGF1R—uterine cancer	0.00272	0.019	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—FGFR2—uterine cancer	0.0026	0.0182	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—STK11—uterine cancer	0.0026	0.0181	CbGpPWpGaD
Papaverine—Anorexia—Doxorubicin—uterine cancer	0.00258	0.00471	CcSEcCtD
Papaverine—Decreased appetite—Epirubicin—uterine cancer	0.00254	0.00465	CcSEcCtD
Papaverine—PDE3B—IRS-related events—FGFR2—uterine cancer	0.00253	0.0177	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—FGFR2—uterine cancer	0.00251	0.0175	CbGpPWpGaD
Papaverine—Constipation—Epirubicin—uterine cancer	0.0025	0.00457	CcSEcCtD
Papaverine—PDE3B—Leptin signaling pathway—ESR1—uterine cancer	0.00246	0.0172	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—FGFR2—uterine cancer	0.00244	0.017	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—FGFR2—uterine cancer	0.00244	0.017	CbGpPWpGaD
Papaverine—Feeling abnormal—Epirubicin—uterine cancer	0.00241	0.0044	CcSEcCtD
Papaverine—Decreased appetite—Doxorubicin—uterine cancer	0.00235	0.0043	CcSEcCtD
Papaverine—Constipation—Doxorubicin—uterine cancer	0.00231	0.00423	CcSEcCtD
Papaverine—Feeling abnormal—Doxorubicin—uterine cancer	0.00223	0.00408	CcSEcCtD
Papaverine—PDE4B—Myometrial Relaxation and Contraction Pathways—YWHAE—uterine cancer	0.00213	0.0149	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—FGFR2—uterine cancer	0.00203	0.0142	CbGpPWpGaD
Papaverine—Diarrhoea—Epirubicin—uterine cancer	0.002	0.00366	CcSEcCtD
Papaverine—Diarrhoea—Doxorubicin—uterine cancer	0.00185	0.00338	CcSEcCtD
Papaverine—Rash—Epirubicin—uterine cancer	0.00184	0.00337	CcSEcCtD
Papaverine—Dermatitis—Epirubicin—uterine cancer	0.00184	0.00337	CcSEcCtD
Papaverine—Headache—Epirubicin—uterine cancer	0.00183	0.00335	CcSEcCtD
Papaverine—PDE3B—Leptin signaling pathway—ERBB2—uterine cancer	0.00181	0.0126	CbGpPWpGaD
Papaverine—Nausea—Epirubicin—uterine cancer	0.00173	0.00317	CcSEcCtD
Papaverine—Rash—Doxorubicin—uterine cancer	0.0017	0.00312	CcSEcCtD
Papaverine—Dermatitis—Doxorubicin—uterine cancer	0.0017	0.00312	CcSEcCtD
Papaverine—Headache—Doxorubicin—uterine cancer	0.00169	0.0031	CcSEcCtD
Papaverine—Nausea—Doxorubicin—uterine cancer	0.0016	0.00294	CcSEcCtD
Papaverine—PDE10A—Hemostasis—IRF1—uterine cancer	0.00158	0.011	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—NRAS—uterine cancer	0.00124	0.00867	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—NRAS—uterine cancer	0.00121	0.00844	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—NRAS—uterine cancer	0.0012	0.00836	CbGpPWpGaD
Papaverine—PDE3B—PI3K Cascade—PIK3CA—uterine cancer	0.00117	0.0082	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—NRAS—uterine cancer	0.00117	0.00814	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—NRAS—uterine cancer	0.00117	0.00814	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—KRAS—uterine cancer	0.00107	0.00747	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—KRAS—uterine cancer	0.00104	0.00726	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—KRAS—uterine cancer	0.00103	0.0072	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKR1B10—uterine cancer	0.00102	0.00715	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—IRF1—uterine cancer	0.00102	0.00713	CbGpPWpGaD
Papaverine—PDE3B—Leptin signaling pathway—HRAS—uterine cancer	0.001	0.00701	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—KRAS—uterine cancer	0.001	0.00701	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—KRAS—uterine cancer	0.001	0.00701	CbGpPWpGaD
Papaverine—PDE4B—G Protein Signaling Pathways—NRAS—uterine cancer	0.001	0.00699	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—PIK3CA—uterine cancer	0.000983	0.00686	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—NRAS—uterine cancer	0.000969	0.00676	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—PIK3CA—uterine cancer	0.000956	0.00667	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—PIK3CA—uterine cancer	0.000947	0.00661	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—IRF1—uterine cancer	0.00093	0.00649	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—PIK3CA—uterine cancer	0.000922	0.00644	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—PIK3CA—uterine cancer	0.000922	0.00644	CbGpPWpGaD
Papaverine—PDE3B—IRS-mediated signalling—HRAS—uterine cancer	0.000909	0.00635	CbGpPWpGaD
Papaverine—PDE3B—Leptin signaling pathway—AKT1—uterine cancer	0.000887	0.00619	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—HRAS—uterine cancer	0.000884	0.00617	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—HRAS—uterine cancer	0.000876	0.00612	CbGpPWpGaD
Papaverine—PDE4B—G Protein Signaling Pathways—KRAS—uterine cancer	0.000862	0.00602	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—HRAS—uterine cancer	0.000853	0.00596	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—HRAS—uterine cancer	0.000853	0.00596	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—RNF43—uterine cancer	0.000848	0.00592	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—KRAS—uterine cancer	0.000834	0.00582	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—INHBA—uterine cancer	0.000776	0.00542	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—PIK3CA—uterine cancer	0.000766	0.00535	CbGpPWpGaD
Papaverine—PDE4B—G Protein Signaling Pathways—HRAS—uterine cancer	0.000733	0.00512	CbGpPWpGaD
Papaverine—PDE3B—Signaling by Insulin receptor—HRAS—uterine cancer	0.000709	0.00495	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKR1C1—uterine cancer	0.000698	0.00488	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKR1B10—uterine cancer	0.000662	0.00462	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKR1B10—uterine cancer	0.000603	0.00421	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKR1B10—uterine cancer	0.000574	0.00401	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RNF43—uterine cancer	0.000549	0.00383	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKR1C3—uterine cancer	0.000538	0.00375	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PGR—uterine cancer	0.000524	0.00366	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—INHBA—uterine cancer	0.000502	0.0035	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RNF43—uterine cancer	0.0005	0.00349	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—YWHAE—uterine cancer	0.0005	0.00349	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—EP300—uterine cancer	0.000493	0.00344	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—FBXW7—uterine cancer	0.000479	0.00335	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RNF43—uterine cancer	0.000475	0.00332	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—VEGFA—uterine cancer	0.000467	0.00326	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—NRAS—uterine cancer	0.000461	0.00322	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—INHBA—uterine cancer	0.000457	0.00319	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKR1C1—uterine cancer	0.000452	0.00316	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—INHBA—uterine cancer	0.000435	0.00304	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—STK11—uterine cancer	0.000419	0.00292	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—CCL2—uterine cancer	0.000417	0.00291	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKR1C1—uterine cancer	0.000412	0.00287	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—KRAS—uterine cancer	0.000397	0.00277	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SOCS3—uterine cancer	0.000392	0.00274	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKR1C1—uterine cancer	0.000392	0.00273	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN2B—uterine cancer	0.000376	0.00262	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IGF1R—uterine cancer	0.000365	0.00255	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—PIK3CA—uterine cancer	0.000364	0.00254	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—CXCL8—uterine cancer	0.000363	0.00253	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—TP53—uterine cancer	0.000353	0.00246	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKR1C3—uterine cancer	0.000348	0.00243	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SMAD3—uterine cancer	0.000343	0.00239	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PGR—uterine cancer	0.000339	0.00237	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—HRAS—uterine cancer	0.000337	0.00235	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—CXCL8—uterine cancer	0.00033	0.0023	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—FGFR2—uterine cancer	0.000327	0.00228	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—YWHAE—uterine cancer	0.000323	0.00226	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—EP300—uterine cancer	0.000319	0.00223	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKR1C3—uterine cancer	0.000317	0.00221	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FBXW7—uterine cancer	0.00031	0.00216	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PGR—uterine cancer	0.000309	0.00216	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—VEGFA—uterine cancer	0.000302	0.00211	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKR1C3—uterine cancer	0.000301	0.0021	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—NRAS—uterine cancer	0.000298	0.00208	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—AKT1—uterine cancer	0.000298	0.00208	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—YWHAE—uterine cancer	0.000295	0.00206	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PGR—uterine cancer	0.000294	0.00205	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—EP300—uterine cancer	0.00029	0.00203	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FBXW7—uterine cancer	0.000282	0.00197	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—YWHAE—uterine cancer	0.00028	0.00196	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—ESR1—uterine cancer	0.00028	0.00195	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—VEGFA—uterine cancer	0.000275	0.00192	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—NRAS—uterine cancer	0.000272	0.0019	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—STK11—uterine cancer	0.000271	0.00189	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CCL2—uterine cancer	0.00027	0.00188	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FBXW7—uterine cancer	0.000269	0.00188	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—NRAS—uterine cancer	0.000264	0.00185	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—KRAS—uterine cancer	0.000257	0.00179	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SOCS3—uterine cancer	0.000254	0.00177	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—STK11—uterine cancer	0.000247	0.00172	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCL2—uterine cancer	0.000246	0.00172	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCL2—uterine cancer	0.000246	0.00172	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN2B—uterine cancer	0.000243	0.0017	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IGF1R—uterine cancer	0.000236	0.00165	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—PIK3CA—uterine cancer	0.000236	0.00165	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—CXCL8—uterine cancer	0.000235	0.00164	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STK11—uterine cancer	0.000235	0.00164	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—KRAS—uterine cancer	0.000234	0.00163	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCL2—uterine cancer	0.000234	0.00163	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SOCS3—uterine cancer	0.000231	0.00161	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—PIK3CA—uterine cancer	0.00023	0.00161	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—TP53—uterine cancer	0.000228	0.00159	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—KRAS—uterine cancer	0.000228	0.00159	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SMAD3—uterine cancer	0.000222	0.00155	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN2B—uterine cancer	0.000221	0.00155	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SOCS3—uterine cancer	0.00022	0.00154	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—HRAS—uterine cancer	0.000218	0.00152	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF1R—uterine cancer	0.000215	0.0015	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—PIK3CA—uterine cancer	0.000215	0.0015	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CXCL8—uterine cancer	0.000214	0.00149	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CXCL8—uterine cancer	0.000213	0.00149	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FGFR2—uterine cancer	0.000212	0.00148	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN2B—uterine cancer	0.000211	0.00147	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PIK3CA—uterine cancer	0.000209	0.00146	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TP53—uterine cancer	0.000208	0.00145	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—ERBB2—uterine cancer	0.000205	0.00143	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1R—uterine cancer	0.000204	0.00143	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CXCL8—uterine cancer	0.000204	0.00142	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SMAD3—uterine cancer	0.000202	0.00141	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—HRAS—uterine cancer	0.000199	0.00139	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CXCL8—uterine cancer	0.000195	0.00136	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CXCL8—uterine cancer	0.000194	0.00136	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—HRAS—uterine cancer	0.000193	0.00135	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGFR2—uterine cancer	0.000193	0.00135	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—AKT1—uterine cancer	0.000193	0.00134	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SMAD3—uterine cancer	0.000192	0.00134	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1B—uterine cancer	0.00019	0.00133	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—AKT1—uterine cancer	0.000188	0.00131	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CXCL8—uterine cancer	0.000185	0.00129	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGFR2—uterine cancer	0.000183	0.00128	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ESR1—uterine cancer	0.000181	0.00126	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CTNNB1—uterine cancer	0.00018	0.00125	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—AKT1—uterine cancer	0.000175	0.00122	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTEN—uterine cancer	0.000175	0.00122	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—NRAS—uterine cancer	0.000171	0.00119	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—AKT1—uterine cancer	0.000171	0.00119	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EP300—uterine cancer	0.000167	0.00117	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ESR1—uterine cancer	0.000165	0.00115	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCL2—uterine cancer	0.000159	0.00111	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—VEGFA—uterine cancer	0.000158	0.0011	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ESR1—uterine cancer	0.000157	0.00109	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NRAS—uterine cancer	0.000156	0.00109	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—NRAS—uterine cancer	0.000156	0.00109	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PIK3CA—uterine cancer	0.000149	0.00104	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—NRAS—uterine cancer	0.000148	0.00104	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—KRAS—uterine cancer	0.000147	0.00103	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCL2—uterine cancer	0.000145	0.00101	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCL2—uterine cancer	0.000138	0.000964	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3CA—uterine cancer	0.000136	0.000948	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3CA—uterine cancer	0.000135	0.000945	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—KRAS—uterine cancer	0.000134	0.000939	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—KRAS—uterine cancer	0.000134	0.000937	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ERBB2—uterine cancer	0.000133	0.000928	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CA—uterine cancer	0.000129	0.000901	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—KRAS—uterine cancer	0.000128	0.000891	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CXCL8—uterine cancer	0.000126	0.00088	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—HRAS—uterine cancer	0.000125	0.000874	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CA—uterine cancer	0.000124	0.000862	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CA—uterine cancer	0.000123	0.00086	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1B—uterine cancer	0.000123	0.000859	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT1—uterine cancer	0.000122	0.00085	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB2—uterine cancer	0.000121	0.000845	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TP53—uterine cancer	0.00012	0.000834	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CA—uterine cancer	0.000117	0.000818	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CTNNB1—uterine cancer	0.000116	0.000812	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB2—uterine cancer	0.000115	0.000804	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CXCL8—uterine cancer	0.000115	0.000801	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—HRAS—uterine cancer	0.000114	0.000798	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—HRAS—uterine cancer	0.000114	0.000796	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTEN—uterine cancer	0.000113	0.000791	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1B—uterine cancer	0.000112	0.000782	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT1—uterine cancer	0.000111	0.000774	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT1—uterine cancer	0.000111	0.000772	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CXCL8—uterine cancer	0.000109	0.000762	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—HRAS—uterine cancer	0.000108	0.000757	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EP300—uterine cancer	0.000108	0.000754	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1B—uterine cancer	0.000107	0.000744	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CTNNB1—uterine cancer	0.000106	0.000739	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT1—uterine cancer	0.000105	0.000736	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTEN—uterine cancer	0.000103	0.00072	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—VEGFA—uterine cancer	0.000102	0.000715	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NRAS—uterine cancer	0.000101	0.000706	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT1—uterine cancer	0.000101	0.000705	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CTNNB1—uterine cancer	0.000101	0.000703	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT1—uterine cancer	0.000101	0.000703	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EP300—uterine cancer	9.84e-05	0.000687	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTEN—uterine cancer	9.82e-05	0.000685	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT1—uterine cancer	9.58e-05	0.000669	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EP300—uterine cancer	9.36e-05	0.000654	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VEGFA—uterine cancer	9.32e-05	0.000651	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NRAS—uterine cancer	9.21e-05	0.000643	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VEGFA—uterine cancer	8.87e-05	0.000619	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NRAS—uterine cancer	8.76e-05	0.000611	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KRAS—uterine cancer	8.7e-05	0.000607	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CA—uterine cancer	7.99e-05	0.000558	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KRAS—uterine cancer	7.93e-05	0.000553	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TP53—uterine cancer	7.73e-05	0.00054	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KRAS—uterine cancer	7.54e-05	0.000526	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HRAS—uterine cancer	7.4e-05	0.000516	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CA—uterine cancer	7.28e-05	0.000508	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TP53—uterine cancer	7.04e-05	0.000492	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CA—uterine cancer	6.93e-05	0.000483	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HRAS—uterine cancer	6.74e-05	0.00047	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TP53—uterine cancer	6.7e-05	0.000468	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT1—uterine cancer	6.53e-05	0.000456	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HRAS—uterine cancer	6.41e-05	0.000447	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT1—uterine cancer	5.95e-05	0.000415	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT1—uterine cancer	5.66e-05	0.000395	CbGpPWpGaD
